SCHEMBL20517853

SCHEMBL20517853

CS(=O)(=O)Nc1ccc(Cl)nc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.43
PIK3CA P42336 4/20 0.43
PIK3CB P42338 4/20 0.43
PIK3CG P48736 4/20 0.43
KEAP1 Q14145 2/20 0.42
GLO1 Q04760 3/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
PTGS1 P23219 3/20 0.40
PTGS2 P35354 3/20 0.40
EP300 Q09472 1/20 0.40
KAT2B Q92831 1/20 0.40
KAT8 Q9H7Z6 1/20 0.40
NFE2L2 Q16236 1/20 0.39
KIF11 P52732 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38
AR P10275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474163 0.83 GLO1 (0.42) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL23363333 0.81 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL1474417 0.79 GLO1 (0.40) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL13040587 0.73 KEAP1 (0.54) KEAP1GLO1ALOX15HTTEP300
SCHEMBL15718645 0.73 SIRT2 (0.36) KAT2B
SCHEMBL4808577 0.72 GLO1 (0.60) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL17261963 0.72 PIK3CA (0.47) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL20470651 0.70 KIF11 (0.37) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL29890839 0.70 KIF11 (0.37) PIK3CDPIK3CAPIK3CBPIK3CGKEAP1
SCHEMBL22029021 0.69 NFE2L2 (0.38) PIK3CDPIK3CAPIK3CBPIK3CGNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117024411-B Isoquinoline as HPK1 inhibitor 豪夫迈·罗氏有限公司 2026-05-19 CN disclosed
CN-117024411-A Isoquinoline as HPK1 inhibitor 豪夫迈·罗氏有限公司 2023-11-10 CN disclosed
CN-110709392-B Isoquinoline as HPK1 inhibitor 豪夫迈·罗氏有限公司 2023-09-29 CN disclosed
US-11566003-B2 Isoquinolines as inhibitors of HPK1 GENENTECH, INC. (US) 2023-01-31 US disclosed
US-11566003-B2 Isoquinolines as inhibitors of HPK1 GENENTECH, INC. (US) 2023-01-31 US disclosed
EP-3601259-B1 ISOQUINOLINES AS INHIBITORS OF HPK1 HOFFMANN LA ROCHE (CH) 2022-02-23 EP disclosed
US-20210163417-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 GENENTECH, INC. (US) 2021-06-03 US disclosed
US-20210163417-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 GENENTECH, INC. (US) 2021-06-03 US disclosed
CN-110709392-A Isoquinoline as HPK1 inhibitors 豪夫迈·罗氏有限公司 2020-01-17 CN disclosed
US-20180282282-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 GENENTECH, INC. (US) 2018-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180282282-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 HIPK1, HPGDS, IP6K1 PIK3CD 1475/4885PIK3CA 1442/4885PIK3CB 1263/4885
US-11566003-B2 Isoquinolines as inhibitors of HPK1 HIPK1, HIPK2, IP6K1 PIK3CD 1327/4885PIK3CA 1155/4885PIK3CB 1106/4885
US-20210163417-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 HIPK1, HIPK2, IP6K1 PIK3CD 1327/4885PIK3CA 1155/4885PIK3CB 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.